121 related articles for article (PubMed ID: 32943689)
1. Efficacy of microbicides for inactivation of Ebola-Makona virus on a non-porous surface: a targeted hygiene intervention for reducing virus spread.
Cutts TA; Robertson C; Theriault SS; Nims RW; Kasloff SB; Rubino JR; Ijaz MK
Sci Rep; 2020 Sep; 10(1):15247. PubMed ID: 32943689
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Dettol Antiseptic Liquid for Inactivation of Ebola Virus in Suspension.
Cutts TA; Ijaz MK; Nims RW; Rubino JR; Theriault SS
Sci Rep; 2019 Apr; 9(1):6590. PubMed ID: 31036865
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes.
Cutts TA; Robertson C; Theriault SS; Nims RW; Kasloff SB; Rubino JR; Ijaz MK
Front Public Health; 2020; 8():183. PubMed ID: 32582604
[TBL] [Abstract][Full Text] [Related]
4. Evaluating environmental persistence and disinfection of the Ebola virus Makona variant.
Cook BW; Cutts TA; Nikiforuk AM; Poliquin PG; Court DA; Strong JE; Theriault SS
Viruses; 2015 Apr; 7(4):1975-86. PubMed ID: 25875372
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Efficacy of Disinfectant Pre-impregnated Wipes for Decontaminating Stainless Steel Carriers Experimentally Inoculated With Ebola Virus and Vesicular Stomatitis Virus.
Cutts TA; Kasloff SB; Krishnan J; Nims RW; Theriault SS; Rubino JR; Ijaz MK
Front Public Health; 2021; 9():657443. PubMed ID: 34447735
[TBL] [Abstract][Full Text] [Related]
6. Development and Testing of a Method for Validating Chemical Inactivation of Ebola Virus.
Alfson KJ; Griffiths A
Viruses; 2018 Mar; 10(3):. PubMed ID: 29533988
[TBL] [Abstract][Full Text] [Related]
7. The Disinfection Characteristics of Ebola Virus Outbreak Variants.
Cook BW; Cutts TA; Nikiforuk AM; Leung A; Kobasa D; Theriault SS
Sci Rep; 2016 Dec; 6():38293. PubMed ID: 27910909
[TBL] [Abstract][Full Text] [Related]
8. The effect of a non-denaturing detergent and a guanidinium-based inactivation agent on the viability of Ebola virus in mock clinical serum samples.
Burton JE; Easterbrook L; Pitman J; Anderson D; Roddy S; Bailey D; Vipond R; Bruce CB; Roberts AD
J Virol Methods; 2017 Dec; 250():34-40. PubMed ID: 28941617
[TBL] [Abstract][Full Text] [Related]
9. Povidone-iodine hand wash and hand rub products demonstrated excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses.
Eggers M; Eickmann M; Kowalski K; Zorn J; Reimer K
BMC Infect Dis; 2015 Sep; 15():375. PubMed ID: 26381737
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of microbicidal actives and formulations for inactivation of Lassa virus in suspension.
Cutts TA; Nims RW; Rubino JR; McKinney J; Kuhn JH; Ijaz MK
Sci Rep; 2023 Aug; 13(1):12983. PubMed ID: 37563252
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of disinfectants for inactivation of Ebola virus in suspension by integrated cell culture coupled with real-time RT-PCR.
Huang Y; Xiao S; Song D; Yuan Z
J Hosp Infect; 2022 Jul; 125():67-74. PubMed ID: 35483643
[TBL] [Abstract][Full Text] [Related]
12. Persistence of Bacteriophage Phi 6 on Porous and Nonporous Surfaces and the Potential for Its Use as an Ebola Virus or Coronavirus Surrogate.
Whitworth C; Mu Y; Houston H; Martinez-Smith M; Noble-Wang J; Coulliette-Salmond A; Rose L
Appl Environ Microbiol; 2020 Aug; 86(17):. PubMed ID: 32591388
[TBL] [Abstract][Full Text] [Related]
13. Ethanol and isopropanol inactivation of human coronavirus on hard surfaces.
Meyers C; Kass R; Goldenberg D; Milici J; Alam S; Robison R
J Hosp Infect; 2021 Jan; 107():45-49. PubMed ID: 32991941
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Four Disinfectants against Ebola Virus on Different Materials.
Smither S; Phelps A; Eastaugh L; Ngugi S; O'Brien L; Dutch A; Lever MS
Viruses; 2016 Jul; 8(7):. PubMed ID: 27399759
[TBL] [Abstract][Full Text] [Related]
15. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
Eickmann M; Gravemann U; Handke W; Tolksdorf F; Reichenberg S; Müller TH; Seltsam A
Transfusion; 2018 Sep; 58(9):2202-2207. PubMed ID: 29732571
[TBL] [Abstract][Full Text] [Related]
17. Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus.
Pinsky BA; Sahoo MK; Sandlund J; Kleman M; Kulkarni M; Grufman P; Nygren M; Kwiatkowski R; Baron EJ; Tenover F; Denison B; Higuchi R; Van Atta R; Beer NR; Carrillo AC; Naraghi-Arani P; Mire CE; Ranadheera C; Grolla A; Lagerqvist N; Persing DH
PLoS One; 2015; 10(11):e0142216. PubMed ID: 26562786
[TBL] [Abstract][Full Text] [Related]
18. Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.
Smither SJ; Weller SA; Phelps A; Eastaugh L; Ngugi S; O'Brien LM; Steward J; Lonsdale SG; Lever MS
J Clin Microbiol; 2015 Oct; 53(10):3148-54. PubMed ID: 26179307
[TBL] [Abstract][Full Text] [Related]
19. Shelf-Life of Chlorine Solutions Recommended in Ebola Virus Disease Response.
Iqbal Q; Lubeck-Schricker M; Wells E; Wolfe MK; Lantagne D
PLoS One; 2016; 11(5):e0156136. PubMed ID: 27244552
[TBL] [Abstract][Full Text] [Related]
20. Differences in the Comparative Stability of Ebola Virus Makona-C05 and Yambuku-Mayinga in Blood.
Schuit M; Miller DM; Reddick-Elick MS; Wlazlowski CB; Filone CM; Herzog A; Colf LA; Wahl-Jensen V; Hevey M; Noah JW
PLoS One; 2016; 11(2):e0148476. PubMed ID: 26849135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
